CWA Asset Management Group LLC purchased a new position in Agilent Technologies, Inc. (NYSE:A – Free Report) in the 3rd ...

Principal Financial Group Inc. trimmed its holdings in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 83.0% ...

Shares of Agilent Technologies Inc. A inched 0.46% higher to $134.28 Wednesday, on what proved to be an all-around great ...

On Monday, Agilent Technologies Inc (A) stock saw a decline, ending the day at $133.86 which represents a decrease of $-2.82 or -2.06% from the prior close of $136.68. The stock opened at $137.2 and ...

In the current market session, Agilent Technologies Inc. A share price is at $131.95, after a 0.31% spike. Moreover, over the ...

Agilent Technologies's A short percent of float has risen 4.07% since its last report. The company recently reported that it has 3.24 million shares sold short, which is 1.28% of all regular shares ...

Agilent Technologies Inc. closed $15.72 below its 52-week high ($155.35), which the company achieved on May 17th. Supported ...

In recent trading, Agilent Technologies Inc (A) stock price has shown some volatility, fluctuating -0.14% over the last five trades and -4.25% over the past 30 trades. This represents a notable shift ...

At every stage, from research to quality control and manufacturing, Agilent can help you make the right choices. Agilent understands your workflows and has a comprehensive portfolio of sample-to ...

Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.